Stock events for Axcelis Technologies, Inc. (ACLS)
Axcelis Technologies' stock (ACLS) has significantly increased, with a 90.14% rise in the past six months and a 155.44% increase over the last 12 months. Recent events include the Q1 2026 earnings report, which showed weaker profitability with net income dropping to $9.2 million. A pending all-stock merger with Veeco Instruments, valued at approximately $4.4 billion, received stockholder approval and is awaiting final clearance from China. CEO Russell Low executed a pre-planned stock sale of 1,244 shares on May 1, 2026.
Demand Seasonality affecting Axcelis Technologies, Inc.’s stock price
Axcelis Technologies anticipates that its full-year 2026 revenue will be second-half weighted, driven by improvements in silicon carbide revenue and continued strength in the memory market. This suggests that demand for Axcelis's equipment and services is stronger in the latter half of the year.
Overview of Axcelis Technologies, Inc.’s business
Axcelis Technologies, Inc. specializes in designing, manufacturing, and servicing capital equipment for the semiconductor manufacturing industry, focusing on ion implantation technology. Its major products include the Purion family of ion implanters and curing systems, catering to memory chips, logic devices, image sensors, and power devices, especially in the silicon carbide (SiC) segment. The company also provides aftermarket lifecycle products and services, including used tools, spare parts, equipment upgrades, maintenance, and customer training.
ACLS’s Geographic footprint
Axcelis Technologies has a global presence with support operations in the U.S., Europe, and Asia, and its products are installed in 28 countries. A significant portion of its revenue comes from the Asia Pacific region, including China, Taiwan, and South Korea. In 2024, international revenue accounted for 85.8% of the company's total revenue.
ACLS Corporate Image Assessment
Axcelis Technologies has maintained a strong brand reputation through innovation and industry engagement. The company launched innovative products like the Purion H6 high-current ion implanter and actively participates in major industry events such as CS Asia 2026 and SEMICON China 2026. Axcelis holds an estimated 70-80% market share in the SiC power device segment, and has long-standing customer relationships.
Ownership
Axcelis Technologies' ownership is predominantly held by institutional investors, who held 101.82% of the shares as of May 2025. Major institutional owners include BlackRock, Inc., and Vanguard Group Inc. Insider holdings increased from 0.78% to 1.25% by May 2025. Public companies and individual investors also hold a portion of the stock.
Ask Our Expert AI Analyst
Price Chart
$150.41